Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

Mouse stem cells from hair follicles can improve wound healing and reduce scarring.

Hormone therapy in transgender women can affect hair growth and acne, and there are specific skin issues related to gender-affirming surgery, but more research is needed on their dermatological health.

The conclusion is that pharmacists are important in helping women choose the right skin care treatments.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

A new treatment using AGED to modulate PPAR-γ shows promise for treating scarring hair loss by protecting and repairing hair follicle cells.

Non-scarring hair loss can be diagnosed with two 4mm punch biopsies, one cut vertically and the other transversely.

Hair loss in twins may be linked to family history of hair loss, high blood pressure, heart disease, and possibly anxiety, but more research is needed.

New effective scar treatments are urgently needed due to the current options' limited success.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

Low-dose oral minoxidil effectively treats non-scarring hair loss with some side effects like hypertrichosis and postural hypotension.

The document suggests that severe hair loss in SLE patients may be an early sign of scalp DLE, treatable with immunosuppressive therapy.

Videodermoscopy is effective for diagnosing different types of non-scarring hair loss.

Trichoscopy is a useful tool for diagnosing hair and scalp disorders.

Clinical exams are good for diagnosing some women's hair loss, but lab tests aren't always needed.

Trichoscopy is effective for diagnosing different types of non-scarring hair loss.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

Dermatologists should understand cultural practices and communicate empathetically to effectively treat skin conditions in children and teens of color.

Vitamin A deficiency changes cattle hair structure, while pregnancy may improve it, suggesting hair can indicate cattle health.

Using psychological treatments can help manage skin conditions along with regular medical care.

The African spiny mouse heals skin without scarring due to different protein activity compared to the common house mouse, which heals with scarring.

Turning scar-forming cells into fat cells can reduce scarring.

Tacrolimus solution is effective and well-tolerated for treating inflammatory scalp conditions.

Skin diseases have a small to moderate impact on the quality of life of patients in Goa, India.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

N-acetyl-GED may help prevent and partially reverse a process that leads to scarring hair loss.